Adaptin Bio, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Adaptin Bio, Inc. (APTN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.58 million shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-11-14
- Adaptin Bio, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.58M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|
| 2025-09-30 | 2.58M shares 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | 2.58M shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 2.58M shares 10-Q · filed 2025-05-15 |